GNLXEarnings•globenewswire•
Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates
Sentiment:Negative (20)
Summary
WESTLAKE VILLAGE, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the second quarter of 2025 and provided general business updates.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 7, 2025 by globenewswire